Southern California Clinical Research Inc is categorized under Health Services in Pasadena, CA and active since 2011.
Southern California Clinical Research Inc was established in 2011, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 600 South Lake Avenue # 105, Pasadena, California CA 91106 or by phoning (626) 844-8848. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Southern California Clinical Research Inc |
| Address: | 600 South Lake Avenue # 105, Pasadena, California 91106 |
| Phone Number: | (626) 844-8848 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2011 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Southern California Clinical Research Inc was started in 2011 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Southern California Clinical Research Inc by calling the company number (626) 844-8848, as your correspondence is most welcome. Additionally, the physical location of the single location of Southern California Clinical Research Inc can be found at the coordinates 34.135659,-118.132115 as well as the street address 600 South Lake Avenue # 105 in Pasadena, California 91106.
For its online presence, you may visit Southern California Clinical Research Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.